SCHEMBL119172

SCHEMBL119172

CCCCCCCCCCOC(=O)C(O)CO

nearest known ligand 0.75

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.59
EPHX1 P07099 1/20 0.50
TSHR P16473 2/20 0.48
USP2 O75604 1/20 0.48
ACHE P22303 6/20 0.47
KDM4E B2RXH2 1/20 0.47
DUSP3 P51452 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL117050 1.00 NAAA (0.59) NAAAEPHX1TSHRUSP2ACHE
SCHEMBL118175 1.00 NAAA (0.59) NAAAEPHX1TSHRUSP2ACHE
SCHEMBL118846 1.00 NAAA (0.59) NAAAEPHX1TSHRUSP2ACHE
SCHEMBL115554 1.00 NAAA (0.59) NAAAEPHX1TSHRUSP2ACHE
SCHEMBL116829 1.00 NAAA (0.59) NAAAEPHX1TSHRUSP2ACHE
SCHEMBL117824 1.00 NAAA (0.59) NAAAEPHX1TSHRUSP2ACHE
SCHEMBL118318 1.00 NAAA (0.59) NAAAEPHX1TSHRUSP2ACHE
SCHEMBL114472 1.00 NAAA (0.59) NAAAEPHX1TSHRUSP2ACHE
Propane SCHEMBL8425587 0.98 NAAA (0.57) NAAAEPHX1TSHRUSP2ACHE
SCHEMBL19031894 0.98 NAAA (0.57) NAAAEPHX1TSHRUSP2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240139106-A1 METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST HERON THERAPEUTICS, INC. 2024-05-02 US claimed
US-11744800-B2 Methods of use of emulsion formulations of an NK-1 receptor antagonist HERON THERAPEUTICS, INC. (US) 2023-09-05 US claimed
US-20230072781-A1 METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST HERCULES CAPITAL, INC., AS AGENT 2023-03-09 US claimed
US-20220160722-A1 STABLE ANTIEMETIC EMULSIONS STEPS BIOSCIENCES, INC. 2022-05-26 US claimed
CN-108431194-B Cleaning agent composition for soldering flux 花王株式会社 2021-02-02 CN claimed
US-10603258-B2 Cleansing composition KAO GERMANY GMBH (DE) 2020-03-31 US claimed
US-20190216768-A1 PREPARATIONS OF TAXANES FOR INTRAVENOUS ADMINISTRATION AND THE PREPARATION METHOD THEREOF JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) 2019-07-18 US claimed
US-10322078-B2 Cosmetic composition containing 3-O-alkyl-L-ascorbic acid or salt thereof AJINOMOTO CO., INC. (JP) 2019-06-18 US claimed
EP-2320863-B1 CLEANSING COMPOSITION KAO GERMANY GMBH (DE) 2018-05-16 EP claimed
EP-2320855-B1 CONDITIONING COMPOSITION FOR HAIR KAO GERMANY GMBH (DE) 2017-12-27 EP claimed
US-20100189596-A1 COMPOSITE EMULSIFIER, AN EMULSION PREPARED FROM IT AND THE PREPARATION METHOD THEREOF SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2010-07-29 US claimed
EP-2184100-A1 A COMPOSITE EMULSIFIER, AN EMULSION PREPARED FROM IT AND THE PREPARATION METHOD THEREOF Shenyang Pharmaceutical University (CN) 2010-05-12 EP claimed
WO-2010025897-A1 CONDITIONING COMPOSITION FOR HAIR KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2010-03-11 WO claimed
WO-2010025896-A1 CONDITIONING COMPOSITION FOR HAIR KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2010-03-11 WO claimed
WO-2010025895-A1 CLEANSING COMPOSITION KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2010-03-11 WO claimed
WO-2010025898-A1 CLEANSING COMPOSITION KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2010-03-11 WO claimed
EP-2161015-A1 Conditioning composition for hair KPSS-Kao Professional Salon Services GmbH (DE) 2010-03-10 EP claimed
EP-2161014-A1 Conditioning composition for hair KPSS-Kao Professional Salon Services GmbH (DE) 2010-03-10 EP claimed
EP-2161017-A1 Cleansing composition KPSS-Kao Professional Salon Services GmbH (DE) 2010-03-10 EP claimed
EP-2161018-A1 Cleansing composition KPSS-Kao Professional Salon Services GmbH (DE) 2010-03-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189596-A1 COMPOSITE EMULSIFIER, AN EMULSION PREPARED FROM IT AND THE PREPARATION METHOD THEREOF PHOSPHO1, LIPA, LIPC NAAA 1017/4885EPHX1 697/4885TSHR 3977/4885
US-10603258-B2 Cleansing composition KRT18, DSG1, KCNH3 NAAA 3840/4885EPHX1 3314/4885TSHR 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.